Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy

Cancer Science

Volumn 99, Issue 12, 2008, Pages 2510-2517

  Zeng, Zhao Chong ^a   Fan, Jia ^a   Tang, Zhao You ^a   Zhou, Jian ^a   Wang, Jian Hua ^a   Wang, Bin Liang ^a   Guo, Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTRODUODENAL ULCER; HUMAN; INFERIOR CAVA VEIN; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OVERALL SURVIVAL; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR THROMBUS; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PORTAL VEIN; PROGNOSIS; SURVIVAL ANALYSIS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VENA CAVA, INFERIOR; YOUNG ADULT;

EID: 57349194288     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00981.x     Document Type: Article

References (33)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
2. Jemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Cancer 2004; 101: 3-27.
3. Pirisi M, Avellini C, Fabris C et al. Portal vein thrombosis in hepatocellular carcinoma: Age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 1998; 124: 397-400.
4. Park KW, Park JW, Choi JI et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2007; doi. 10.1111/j.1440-1746.200705112.x.
5. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western Center. Ann Surg 1999; 229: 790-800.
6. Cheung TK, Lai CL, Wong CY, Fung J, Yuen MF. Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong. Aliment Pharmacol Ther 2006; 24: 573-83.
7. Takizawa D, Kakizaki S, Sohara N et al. Hepatocellular carcinoma with portal vein tumor thrombosis: Clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 2007; 52: 3290-5.
8. Liovet JM, Bustamante J, Castells A et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology 1999; 29: 62-7.
9. Cheong JY, Lee KM, Cho SW et al. Survival benefits to intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res 2005; 32: 127-33.
10. Jang JW, Bae SH, Choi JY et al. A combination therapy with transarterial chemo-lipoidolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Cancer Chemother Pharmacol 2007; 59: 9-15.
11. Minagawa M, Makuuchi M, Takayama T et al. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233: 379-84.
12. Ikai I, Hatano E, Hasegawa S et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 2006; 202: 431-8.
13. Zeng ZC, Fan J, Tang ZY et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys 2005; 61: 432-43.
14. Kim DY, Park W, Lim DH et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005; 103: 2419-26.
15. Toya R, Murakami R, Baba Y et al. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol 2007; 84: 266-71.
16. Lin CS, Jen YM, Chiu SY et al. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy. Jpn J Clin Oncol 2006; 36: 212-17.
17. Frazer C. Imaging of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14: 750-6.
18. Loyer EM, Chin H, DuBrow RA et al. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: Enhancement patterns with quadruple phase helical CT -a comparative study. Radiology 1999; 212: 866-75.
19. Blacher A, Federle MP, Ferris JV et al. Radiologists'performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 2002; 223: 532-9.
20. Chinese Liver Cancer Association. The diagnostic criteria and stages of primary hepatoma in the 4th national conference of liver cancer. Problems and discussion. Chin J Gen Surg 2000; 15: 238-9.
21. Zeng ZC. Conformal radiation therapy for patients with unresectable primary liver cancerCRT is now a realistic option. Austral-Asian J Cancer 2008; 7 (2): 65-75.
22. Du SS, Zeng ZC, Wu Z et al. Clinical value of active breathing coordinator during three dimension conformal radiotheapy for patients with intrahepatic tumor. Austral-Asian J Cancer 2008; 7: 15-23.
23. Tazawa J, Maeda M, Sakai Y et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 2001; 16: 660-5.
24. Ishikura S, Ogino T, Furuse J et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 2002; 25: 189-93.
25. Yamada K, Izaki K, Sugimoto K et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 113-19.
26. Hwang SJ, Luo JC, Li CP et al. Thrombocytosis: A paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2472-7.
27. Zhang SM, Zeng ZC, Tang ZY et al. Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Hepatol Int 2008; 2: 237-43.
28. Hagiwara S, Kudo M, Kawasaki T et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol 2006; 41: 1214-19.
29. Sakar B, Ustuner Z, Karagol H, Aksu G, Camlica H, Aykan NF. Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis. Am J Clin Oncol 2004; 27: 489-93.
30. Reichman TW, Bahramipour P, Barone A et al. Hepatitis status, Child-Pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable HCC. J Gastrointest Surg 2005; 9: 638-45.
31. O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 2003; 90: 325-31.
32. Webb NJA, Bottomley MJ, Watson CJ, Brenchley PEC. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 1998; 94: 395-404.
33. Poon RT, Lau CP, Cheung S, Yu WC, Fan S. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res 2003; 63: 3121-6.